Dorothy K Hatsukami, Xianghua Luo, Alisa K Heskin, Mei Kuen Tang, Steven G Carmella, Joni Jensen, Jason D Robinson, Ryan Vandrey, David J Drobes, Andrew A Strasser, Mustafa al'Absi, Scott Leischow, Paul M Cinciripini, Joseph Koopmeiners, Joshua Ikuemonisan, Neal L Benowitz, Eric C Donny, Stephen S Hecht
Journal: Addiction (Abingdon, England) 2020;114(10):1824-1833
PMID: 31140663
AIM
A previous study showed significantly greater reductions in number of cigarettes smoked and biomarkers of toxicant and carcinogen exposure in smokers assigned to immediate reduction of nicotine in cigarettes to very low levels versus gradually over time or continued smoking of normal nicotine content cigarettes. This study examines the effects of these approaches on selected biomarkers associated with harmful biological effects.
DESIGN
Three-arm, randomized controlled trial.
SETTING
Ten United States academic institutional sites.
PARTICIPANTS
Daily smokers uninterested in quitting smoking with a mean age of 45.1 [standard deviation (SD) = 13.4)] years and smoking 17.1 (SD = 8.5) cigarettes/day; 43.9% (549 of 1250) female; 60.6% (758 of 1250) white ethnicity.
INTERVENTIONS
(1) Smoking cigarettes where nicotine content was immediately reduced to very low levels (n = 503); (2) smoking cigarettes where nicotine content was gradually reduced, with dose changes occurring monthly (n = 498); and (3) continued smoking with normal nicotine content cigarettes (n = 249).
MEASUREMENTS
Smokers were assessed at baseline while smoking their usual brand cigarettes, and again at 4, 8, 12, 16 and 20 weeks. Outcomes were areas under the concentration time curve (AUC) for the period of study of biomarkers of inflammation, oxidative stress and hematological parameters.
FINDINGS
No consistent significant differences were observed across groups (Bayes factors showing data to be insensitive), with the only exception being red blood cell size variability, which was observed to be lower in the immediate versus gradual nicotine reduction [mean difference = -0.11; 95% confidence interval (CI) = -0.18, -0.04, P = 0.004] and normal nicotine control groups (mean difference = - 0.15, 95% CI = -0.23, -0.06, P = 0.001).
CONCLUSION
It remains unclear whether switching to very low nicotine cigarettes leads to a short-term reduction in biomarkers of tobacco-related harm.
© 2019 Society for the Study of Addiction.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.